The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ethylenediaminetetraacetic acid (EDTA) blood collection tubes (BCTs). However, the integrity of samples collected in these tubes often suffers during the collection, transportation, and processing stages. Novel BCTs can now maintain the draw-time concentrations of plasma proteins and minimize the interference of contaminating proteins released through ex vivo hemolysis and platelet activation.
MODIFIED FROM © ISTOCK.COM, Laboko, ttsz, PenWin, chromatos, Rujirat Boonyong; Designed by AnnaMaria Vasco
Learn more about how innovative BCTs improve plasma protein analysis.
